Vitamin K: Key vitamin in controlling vascular calcification in chronic kidney disease

Kidney International

Volumn 83, Issue 5, 2013, Pages 782-784

  Schurgers, Leon J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; MENATETRENONE; OSTEOCALCIN; PHYTOMENADIONE; PROTHROMBIN; SEVELAMER; VITAMIN K GROUP;

ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL CALCIFICATION; CARBOXYLATION; CHRONIC KIDNEY DISEASE; CORONARY ARTERY CALCIFICATION; HEART INFARCTION; HUMAN; HYPERPHOSPHATEMIA; INTERSTITIAL NEPHRITIS; ISCHEMIC HEART DISEASE; KIDNEY FIBROSIS; MINERALIZATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SECONDARY HYPERPARATHYROIDISM; THROMBOSIS; UREMIA; VITAMIN INTAKE; VITAMIN K DEFICIENCY;

EID: 84877062937     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.26     Document Type: Note

References (10)

1. Drueke TB, Massy ZA. Atherosclerosis in CKD: differences from the general population. Nat Rev Nephrol 2010; 6: 723-735.
2. McCabe KM, Booth SL, Fu X et al. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int 2013; 83: 835-844.
3. De Schutter TM, Neven E, Persy VP et al. Vascular calcification is associated with cortical bone loss in chronic renal failure rats with and without ovariectomy: the calcification paradox. Am J Nephrol 2011; 34: 356-366.
4. Holden RM, Morton AR, Garland JS et al. Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol 2010; 5: 590-597.
5. Cranenburg ECM, Schurgers LJ, Uiterwijk HH et al. Vitamin K intake and status are low in hemodialysis patients. Kidney Int 2012; 82: 605-610.
6. Westenfeld R, Krueger T, Schlieper G et al. Effect of vitamin K(2) supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis 2012; 59: 186-195.
7. Block GA, Wheeler DC, Persky MS et al. Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 2012; 23: 1407-1415.
8. Schurgers LJ, Joosen IA, Laufer EM et al. Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype. PLoS One [online] 2012; 7: e43229.
9. Chatrou MLL, Winckers K, Hackeng TM et al. Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists. Blood Rev 2012; 26: 155-166.
10. Geleijnse JM, Vermeer C, Grobbee DE et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004; 134: 3100-3105.